These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
249 related items for PubMed ID: 16124994
1. Prolactin and growth hormone signaling. Chilton BS, Hewetson A. Curr Top Dev Biol; 2005; 68():1-23. PubMed ID: 16124994 [Abstract] [Full Text] [Related]
2. Growth hormone-mediated janus associated kinase-signal transducers and activators of transcription signaling in the growth hormone-resistant potassium-deficient rat. Schaefer F, Yoon SA, Nouri P, Tsao T, Tummala P, Deng E, Rabkin R. J Am Soc Nephrol; 2004 Sep; 15(9):2299-306. PubMed ID: 15339979 [Abstract] [Full Text] [Related]
3. Downregulation of the growth hormone-induced Janus kinase 2/signal transducer and activator of transcription 5 signaling pathway requires an intact actin cytoskeleton. Rico-Bautista E, Negrín-Martínez C, Novoa-Mogollón J, Fernández-Perez L, Flores-Morales A. Exp Cell Res; 2004 Mar 10; 294(1):269-80. PubMed ID: 14980520 [Abstract] [Full Text] [Related]
4. Prolactin, growth hormone, and epidermal growth factor activate Stat5 in different compartments of mammary tissue and exert different and overlapping developmental effects. Gallego MI, Binart N, Robinson GW, Okagaki R, Coschigano KT, Perry J, Kopchick JJ, Oka T, Kelly PA, Hennighausen L. Dev Biol; 2001 Jan 01; 229(1):163-75. PubMed ID: 11133161 [Abstract] [Full Text] [Related]
5. Janus kinase 2 (JAK2) regulates prolactin-mediated chloride transport in mouse mammary epithelial cells through tyrosine phosphorylation of Na+-K+-2Cl- cotransporter. Selvaraj NG, Omi E, Gibori G, Rao MC. Mol Endocrinol; 2000 Dec 01; 14(12):2054-65. PubMed ID: 11117534 [Abstract] [Full Text] [Related]
11. Increased sensitivity to GH in liver of Ames dwarf (Prop1df/Prop1df) mice related to diminished CIS abundance. Miquet JG, Sotelo AI, Dominici FP, Bonkowski MS, Bartke A, Turyn D. J Endocrinol; 2005 Dec 01; 187(3):387-97. PubMed ID: 16423818 [Abstract] [Full Text] [Related]
12. Growth hormone resistance in uremia, a role for impaired JAK/STAT signaling. Rabkin R, Sun DF, Chen Y, Tan J, Schaefer F. Pediatr Nephrol; 2005 Mar 01; 20(3):313-8. PubMed ID: 15692835 [Abstract] [Full Text] [Related]
13. Prolactin signals through RUSH/SMARCA3 in the absence of a physical association with Stat5a. Hewetson A, Moore SL, Chilton BS. Biol Reprod; 2004 Dec 01; 71(6):1907-12. PubMed ID: 15306550 [Abstract] [Full Text] [Related]
14. Impaired alveologenesis and maintenance of secretory mammary epithelial cells in Jak2 conditional knockout mice. Wagner KU, Krempler A, Triplett AA, Qi Y, George NM, Zhu J, Rui H. Mol Cell Biol; 2004 Jun 01; 24(12):5510-20. PubMed ID: 15169911 [Abstract] [Full Text] [Related]
18. Growth hormone (GH), GH receptor, and signal transduction. Kopchick JJ, Andry JM. Mol Genet Metab; 2000 Jun 01; 71(1-2):293-314. PubMed ID: 11001823 [No Abstract] [Full Text] [Related]
19. CIS1 interacts with the Y532 of the prolactin receptor and suppresses prolactin-dependent STAT5 activation. Endo T, Sasaki A, Minoguchi M, Joo A, Yoshimura A. J Biochem; 2003 Jan 01; 133(1):109-13. PubMed ID: 12761205 [Abstract] [Full Text] [Related]
20. Down-regulation of liver JAK2-STAT5b signaling by the female plasma pattern of continuous growth hormone stimulation. Gebert CA, Park SH, Waxman DJ. Mol Endocrinol; 1999 Feb 01; 13(2):213-27. PubMed ID: 9973252 [Abstract] [Full Text] [Related] Page: [Next] [New Search]